MGV vs XLV
Vanguard Mega Cap Value ETF vs Health Care Select Sector SPDR Fund
- • MGV has the lower expense ratio at 0.05% vs 0.08% for XLV.
- • MGV pays a higher dividend yield (1.96%).
Side-by-side metrics
| Metric | MGV | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.05% | 0.08% |
Dividend yield Trailing 12-month yield. | 1.96% | 1.72% |
AUM Assets under management — bigger funds are typically more liquid. | $12.14B | $37.88B |
YTD return | 9.67% | -5.69% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.70 | 0.58 |
P/E ratio | 22.59 | 26.68 |
Last price | $152.65 | $144.72 |
Inception | — | — |
Issuer | Vanguard | State Street |
MGV top holdings
| JPM | JPMorgan Chase & Co | 3.86% |
| XOM | Exxon Mobil Corp | 3.69% |
| BRK-B | Berkshire Hathaway Inc Class B | 3.43% |
| JNJ | Johnson & Johnson | 3.08% |
| WMT | Walmart Inc | 2.84% |
| COST | Costco Wholesale Corp | 2.31% |
| CVX | Chevron Corp | 2.05% |
| ABBV | AbbVie Inc | 2.01% |
| MU | Micron Technology Inc | 1.98% |
| PG | Procter & Gamble Co | 1.75% |
XLV top holdings
| LLY | Eli Lilly and Co | 14.07% |
| JNJ | Johnson & Johnson | 10.52% |
| ABBV | AbbVie Inc | 7.10% |
| UNH | UnitedHealth Group Inc | 6.38% |
| MRK | Merck & Co Inc | 5.15% |
| AMGN | Amgen Inc | 3.54% |
| TMO | Thermo Fisher Scientific Inc | 3.42% |
| ISRG | Intuitive Surgical Inc | 3.09% |
| GILD | Gilead Sciences Inc | 3.08% |
| ABT | Abbott Laboratories | 3.00% |
About MGV
MGV (Vanguard Mega Cap Value ETF) is Mega-cap US value stocks. Managed by Vanguard, the fund carries $12.1B in assets under management, an expense ratio of 0.05%, a dividend yield of 1.96%. Its largest holding is JPMorgan Chase & Co (JPM), which represents 3.9% of the portfolio. Real Estate is the fund's largest sector exposure at 1.2%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $37.9B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.72%. Its largest holding is Eli Lilly and Co (LLY), which represents 14.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.